Cares Built, an x-ray and general radiographic company, has received 510(k) clearance from the FDA for the Hercules 7000, its new motor-driven mobile x-ray system.The Hercules 7000 is capable of 500-mA x-rays and is designed to move between exam
Cares Built, an x-ray and general radiographic company, has received 510(k) clearance from the FDA for the Hercules 7000, its new motor-driven mobile x-ray system.
The Hercules 7000 is capable of 500-mA x-rays and is designed to move between exam rooms or to have great flexibility in one room, according to the firm. Features of the system include a one-step articulating arm with rotation and a dual power supply that enhances positioning and propulsion capabilities, said Tim Telymonde, president and CEO.
Administrators at St. Louis University Hospital have ordered the first system from the New Jersey-based company, said Kenneth Alderfer, Cares Built spokesperson. The Hercules 7000 will be displayed at this years Radiological Society of North America trade show in November. Cares Built also manufactures the Clarity 7000 direct digital x-ray system.
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.